These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7269051)

  • 41. [Treatment of patients with malignant laryngeal and pharyngeal neoplasms].
    Pogosov VS; Sarkisova FR; Smetanin IG
    Vestn Otorinolaringol; 1995; (4):5-8. PubMed ID: 7676564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Radiation and drug treatment of neglected forms of laryngeal cancer].
    Morozov AI; Rogachikova TA; Deviatykh IuN
    Med Radiol (Mosk); 1975 Oct; 20(10):27-32. PubMed ID: 1207420
    [No Abstract]   [Full Text] [Related]  

  • 43. [Calcium metabolism in patients with laryngeal cancer before and after radiotherapy].
    Shadyev KhD; Kokoleva EM
    Vestn Otorinolaringol; 2003; (1):28-9. PubMed ID: 12666596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The determination of the optimal irradiation dose in the tumor tissue-normal body tissues system].
    Klepper LIa
    Med Tekh; 1997; (4):18-21. PubMed ID: 9379858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of diffused laryngeal and pharyngeal cancer with preoperative radiotherapy in combination with radiation-modifying agents].
    Andreev VG; Romanko IuS
    Vestn Otorinolaringol; 1995; (4):13-6. PubMed ID: 7676553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).
    Nakamura K; Kodaira T; Shikama N; Kagami Y; Ishikura S; Shibata T; Hiraoka M
    Jpn J Clin Oncol; 2008 May; 38(5):387-9. PubMed ID: 18390558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of results from radiotherapy and combined treatment of laryngeal cancer (surgery and radiotherapy) considering differentiation of procedures with respect to lymph nodes in the neck].
    Rogowska D
    Ann Acad Med Stetin; 1996; 42():177-97. PubMed ID: 9199120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dermatomyositis as a complication of the radiotherapy of laryngeal cancer].
    Tsvetkov EA
    Med Radiol (Mosk); 1977 Jul; 22(7):78-9. PubMed ID: 909372
    [No Abstract]   [Full Text] [Related]  

  • 51. Radiotherapeutic management of laryngeal carcinoma.
    Hristov B; Bajaj GK
    Otolaryngol Clin North Am; 2008 Aug; 41(4):715-40, vi. PubMed ID: 18570955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Complications in radiotherapy of laryngeal cancer].
    Chochia KN; Rabinovich RM; Polezhaev AB
    Vopr Onkol; 1965; 11(12):25-31. PubMed ID: 5875742
    [No Abstract]   [Full Text] [Related]  

  • 53. [The connection between clinical stage and dosetime ratio in laryngeal cancer (author's transl)].
    Ghilezan N
    Radiobiol Radiother (Berl); 1975; 16(3):271-7. PubMed ID: 1215486
    [No Abstract]   [Full Text] [Related]  

  • 54. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
    Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
    Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glottic cancer with subglottic extension.
    Ampil FL; Menezes CA
    Radiat Med; 1997; 15(2):103-7. PubMed ID: 9192435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.
    Ahmed WA; Suzuki K; Imaeda Y; Horibe Y
    Auris Nasus Larynx; 2008 Jun; 35(2):213-9. PubMed ID: 17996416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining the criteria for radioresistant laryngeal cancer.
    Nix PA; Greenman J; Cawkwell L; Stafford ND
    Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):705-8. PubMed ID: 15533164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
    Lo SM; Venkatesan V; Matthews TW; Rogers J
    J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinico-anatomical parallels in treatment of laryngeal cancer].
    Lushnikov EF; Seniukov MV
    Med Radiol (Mosk); 1976 May; 21(5):15-22. PubMed ID: 972582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.